
PART 1: Personal Style Assessment. You will start by completing a specially designed intake questionnaire about your interests and preferences related to careers in general.
PART 2: The Highlands Ability Battery. The Highlands Ability Battery™ is the gold standard in testing career-related abilities.
The Battery is a series of 19 timed work-samples that measure and define your natural abilities. This is not like any other test you've ever taken. There are no grades or no good or bad results. Each work-sample measures a particular aptitude and you'll be amazed how much they reveal about you.
Opposed to interest or personality testing, you cannot influence the Highlands Ability Battery to produce false results.
How accurate is it? This is not like the aptitude testing from years ago, or the tests available in certain books out there. The information and suggestions that it makes are HIGHLY ACCURATE. The testing is psychometrically valid and reliable. The minimum reliability standard for the 19 tests that make up The Highlands Ability Battery is r
= . 80.
After you complete the Battery, you will receive a 33-page report describing your results in detail.
PART 3: Oxford CareerFitNow Analysis. The Oxford CareerFITNow Analysis will analyze your interest patterns, providing a window into your personality and "role in life".
In addition to your abilities discovered with the Highlands Ability Battery, this assessment allows us to understand what fields satisfy your interests and will provide you the motivation to be happy and successful.
You receive your CareerFITNow report which compares your natural inclinations to the results of people who are successfully employed in professions and provide recommendations on specialties matching your talents and interests.
After you have completed the testing, your results will be used to create a report which explains what they mean, along with profile matches.
After the testing is complete, you will have a follow-up feedback and interpretation session with the Oxford Program founder, Steve Bohler, to discuss the results.